Actively Recruiting

Phase Not Applicable
Age: 18Years - 85Years
All Genders
NCT07209488

Acquired Dyslexia Modeling and Treatment

Led by Rutgers, The State University of New Jersey · Updated on 2026-05-06

12

Participants Needed

3

Research Sites

38 weeks

Total Duration

On this page

Sponsors

R

Rutgers, The State University of New Jersey

Lead Sponsor

N

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study is a low-risk, early phase 1, multicenter trial to test the use of a computational (neural network) cognitive model of reading to simulate acquired dyslexia and its treatment. The aim is to determine whether there is an advantage to receiving the treatment the model predicts to be advantageous compared to the alternative treatment. All participants will receive two full rounds of treatment. A round of treatment will consist of either phonomotor treatment (PMT) or semantic feature analysis (SFA) for 60 hours, distributed over 5 days a week for 2 hours a day.

CONDITIONS

Official Title

Acquired Dyslexia Modeling and Treatment

Who Can Participate

Age: 18Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Fluent in English as a first language before stroke by self report
  • Normal or corrected-to-normal vision
  • Normal or aided hearing
  • Left hemisphere ischemic or hemorrhagic stroke confirmed by a brain scan
  • Impaired reading as shown by significant impairment in the Basic Skills cluster of the Woodcock Reading Mastery Test - III
Not Eligible

You will not qualify if you...

  • Diagnosed neurological disease affecting the brain before stroke other than left hemisphere stroke
  • Severe apraxia of speech determined by speech-language pathologists
  • History of learning disabilities such as developmental dyslexia
  • Current self-reported major psychiatric disorders
  • Inability to undergo or provide a post-stroke brain imaging scan

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Florida State University

Tallahassee, Florida, United States, 32306

Actively Recruiting

2

Johns Hopkins University School of Medicine

Baltimore, Maryland, United States, 21287

Actively Recruiting

3

Kessler Foundation

West Orange, New Jersey, United States, 07052

Actively Recruiting

Loading map...

Research Team

W

William W Graves, PhD

CONTACT

O

Olga Boukrina, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

NON_RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here